From a mono-sectoral colistin ban in the poultry sector to a multi-sectoral community-based One Health intervention: Impact of reducing colistin use on colistin resistance in humans and poultry in Indonesia

从家禽行业的单部门粘菌素禁令到基于社区的多部门“One Health”干预措施：减少粘菌素使用对印度尼西亚人类和家禽粘菌素耐药性的影响

• 批准号: 450318
• 负责人: Barkema Herman W
• 金额: $ 12.2万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-07-01 至 2024-07-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=450318&lang=en
• 关键词: Amr Transmission; Colistin Ban; Colistin Resistance; Community-Based Intervention; Gender And Socio-Cultural Factors; Human Health; One Health; Poultry

Colistin (polymyxin E) is considered a last resort antimicrobial for treatment of infections with multidrug- resistant bacteria, classified by WHO as 'highest prioritized, critically important for human medicine'. WHO suggests to ban or highly restrict it

粘菌素（多粘菌素E）被认为是治疗多重耐药细菌感染的最后手段抗菌剂，被WHO归类为“最高优先级，对人类医学至关重要”。世卫组织建议禁用或高度限制